PTK2 and squamous cell carcinoma: Recently, it has been reported that loss of E-cadherin in cell models of incipient stages of squamous cell carcinoma drives the upregulation of FAK mRNA and protein levels as well as FAK/Src activities (Alt-Holland et al., 2011).